Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NTLA

Intellia Therapeutics Inc

May 22 • 04:00PM ET

12.60

+0.23 1.86 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: BEAM CRSP PRME EDIT SANA

| Held by: ARKK VTI XBI VB ARKG IWM VBK VXF IWN IBB

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.53	Insider Own	5.31%	Shs Outstand	139.72M	Perf Week	-7.83%
Market Cap	1.76B	Forward P/E	-	EPS next Y	-1.90	Insider Trans	-0.32%	Shs Float	132.30M	Perf Month	-20.60%
Enterprise Value	1.47B	PEG	-	EPS next Q	-0.81	Inst Own	76.19%	Short Float	32.90%	Perf Quarter	-4.26%
Income	-394.60M	P/S	26.64	EPS this Y	15.47%	Inst Trans	8.13%	Short Ratio	7.81	Perf Half Y	52.91%
Sales	66.09M	P/B	2.44	EPS next Y	41.13%	ROA	-45.23%	Short Interest	43.53M	Perf YTD	40.16%
Book/sh	5.16	P/C	4.68	EPS next 5Y	43.40%	ROE	-56.34%	52W High	28.25 -55.40%	Perf Year	33.19%
Cash/sh	2.69	P/FCF	-	EPS past 3/5Y	14.82% -9.70%	ROIC	-57.83%	52W Low	6.83 84.48%	Perf 3Y	-71.62%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	9.09% 3.13%	Gross Margin	76.32%	Volatility	7.11% 8.88%	Perf 5Y	-80.15%
Dividend TTM	-	EV/Sales	22.17	EPS Y/Y TTM	32.42%	Oper. Margin	-636.56%	ATR (14)	1.03	Perf 10Y	-53.57%
Dividend Ex-Date	-	Quick Ratio	6.10	Sales Y/Y TTM	45.04%	Profit Margin	-597.04%	RSI (14)	44.33	Recom	2.22
Dividend Gr. 3/5Y	- -	Current Ratio	6.10	EPS Q/Q	26.48%	SMA20	-5.11%	Beta	1.91	Target Price	26.61
Payout	-	Debt/Eq	0.13	Sales Q/Q	-9.50%	SMA50	-7.05%	Rel Volume	0.57	Prev Close	12.37
Employees	377	LT Debt/Eq	0.10	Earnings	May 11 BMO	SMA200	-4.74%	Avg Volume	5.58M	Price	12.60
IPO	May 06, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	11.06% 8.99%	Trades		Volume	3,192,047	Change	1.86%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)